Bunkerhill Health vs CureMetrix
CureMetrix and Bunkerhill each look for calcium in images taken for another reason, breast arterial calcification on mammograms and coronary calcium on CT, and the images differ. CureMetrix reads screening mammograms for breast arterial calcification. Its cmAngio has FDA decisions from October 2023 through version 2.0 in July 2026, and ITN reports validation on Hologic and then GE platforms. The AUC of 0.98 to 0.992 and the 400-plus US sites are the vendor's own figures. A breast imaging center that wants calcification reported with every screening read is the buyer.
Bunkerhill is sold to health systems. Its homepage lists heart failure follow-up for patients with an ejection fraction of 40% or below, and its cleared tools include gated and contrast coronary calcium and an ECG-based ejection fraction algorithm.
A preventive cardiology program whose target is coronary calcium falls short with cmAngio, which quantifies breast arterial calcification, while Bunkerhill's gated and contrast CAC algorithms address the coronary arteries.
Radiology · Reviewed November 1, 2026
Bunkerhill Health
by Bunkerhill Health
AI agent platform for health systems covering referrals, prior auth, care coordination and imaging, built on nine FDA-cleared imaging algorithms.
CureMetrix
by CureMetrix
AI for mammograms: cmAngio quantifies breast arterial calcification (FDA-cleared), cmTriage prioritizes screening exams.
When to pick each one
Bunkerhill Health
- Gated and contrast CAC, latest decision March 2026
- Heart failure follow-up for patients with LVEF 40% or below
CureMetrix
- cmAngio breast arterial calcification, K260980 (July 2026)
- ITN reports validation on Hologic, then GE platforms
- Vendor claims AUC 0.98 to 0.992, 400+ US sites
Score
Each row shows points earned of points available under the published rubric.
Bunkerhill Health
40of 100
CureMetrix
48of 100
| Dimension | Bunkerhill Health | CureMetrix | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 10 / 10 | 0 / 10 | +10 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 0 / 18.2 | 12.7 / 18.2 | -12.7 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 3.9 / 7.8 | -3.9 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Bunkerhill Health
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Quote only | n/a | n/a | No public price. The site offers a demo request only. |
CureMetrix
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The homepage shows none. |
Evidence
Bunkerhill Health
FDA decisions
K260167 (opens in new tab)510(k)2026-03-06
Bunkerhill Contrast AVC
K260166 (opens in new tab)510(k)2026-03-06
Bunkerhill Contrast CAC
K250662 (opens in new tab)510(k)2025-10-03
Bunkerhill MAC
K250649 (opens in new tab)510(k)2025-09-19
Bunkerhill ECG-EF
K243779 (opens in new tab)510(k)2025-07-01
Bunkerhill Abdominal Aortic Quantification (AAQ)
Show 4 more
K242295 (opens in new tab)510(k)2025-04-08
BunkerHill BMD
K243229 (opens in new tab)510(k)2025-01-27
Bunkerhill AVC
K240369 (opens in new tab)510(k)2024-09-27
CAC (gated) Algorithm
K230223 (opens in new tab)510(k)2023-04-25
iCAC Device
CureMetrix
FDA decisions
K260980 (opens in new tab)510(k)2026-07-30
cmAngio V2.0
K250754 (opens in new tab)510(k)2025-04-10
cmAngio V1.6
K232367 (opens in new tab)510(k)2023-10-05
cmAngio V1.0
K183285 (opens in new tab)510(k)2019-03-08
cmTriage
Peer-reviewed
3 PubMed records name CureMetrix.
- A Novel Breast Arterial Calcification Age-Based Percentile Nomogram for the Incremental Prediction of Incidental Cardiovascular Events. (opens in new tab)
- Evaluation of an Artificial Intelligence System for Detection of Invasive Lobular Carcinoma on Digital Mammography. (opens in new tab)
- Multicenter, Multivendor Validation of an FDA-approved Algorithm for Mammography Triage. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Bunkerhill Health | CureMetrix |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | n/a | US |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.